CNBX News and Press, Cannabics Pharmaceuticals Inc From 01/29/20

5 Penny Stocks To Watch Before Friday This week we’ve seen a crazy mix of health concerns and economic uncertainty push the market all over the place. However, following the initial drop, the market has started to recover. Lack of volatility can make investors look for places where ther...

TEL AVIV , Israel and BETHESDA, Maryland, Jan. 27, 2020 /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a series of tests conducted a...

TEL AVIV , Israel and BETHESDA, Maryland, Jan. 9, 2020 /PRNewswire/ --   Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a pre-clinical study held at th...

TEL AVIV , Israel and BETHESDA, Maryland , Dec. 5, 2019 /PRNewswire/ --   Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that Dr. Yaakov Waksman is to join the com...

TEL AVIV, Israel and BETHESDA, Maryland , Oct. 16, 2019 /PRNewswire/ --   Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the final results of its pilot study to test the...

TEL AVIV, Israel and BETHESDA, Maryland , Oct. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid based cancer medicine, today announced that it has appointed the Company's Founder as a new Director and Member of its Board. ...

TEL AVIV , Israel and BETHESDA, Maryland , Sept. 12, 2019 /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTC-QB: CNBX), a leader in personalized cannabis based cancer medicine, today announced that its Scientific Director, Dr. Ilan Hochman , is scheduled to p...

Investment thesis It is very important that readers of this article are acutely aware that investment in the marijuana segment is littered with more potholes than Boston's Financial District . The pronounced volatility of many of the stocks trading in this space is a cautionary tale for tho...

HOD HASHARON, Israel , June 28, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that the Company and Cannabics Pharmaceuticals (OTCQB: CNBX) have together created and adop...

The following slide deck was published by Cannabics Pharmaceuticals Inc. in conjunction with this Read more ...